檢索結果 - Francesco Iachetta
- Showing 1 - 2 results of 2
-
1
Results of the observational prospective RealFLOT study 由 Elisa Giommoni, Daniele Lavacchi, Giuseppe Tirino, Lorenzo Fornaro, Francesco Iachetta, Carmelo Pozzo, Maria Antonietta Satolli, Andrea Spallanzani, Marco Puzzoni, Silvia Stragliotto, Michele Sisani, Vincenzo Formica, Filippo Giovanardi, Antonia Strippoli, Michele Prisciandaro, Samantha Di Donato, Luca Pompella, Irene Pecora, Alessandra Romagnani, Sara Fancelli, Marco Brugia, Serena Pillozzi, Ferdinando De Vita, Lorenzo Antonuzzo
出版 2021Artigo -
2
TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The... 由 Alessandra Raimondi, Federica Palermo, Michele Prisciandaro, Massimo Aglietta, Lorenzo Antonuzzo, Giuseppe Aprile, Rossana Berardi, Giovanni Gerardo Cardellino, Giovanni De Manzoni, Ferdinando De Vita, Massimo Di Maïo, Lorenzo Fornaro, Giovanni Luca Frassineti, Cristina Granetto, Francesco Iachetta, Sara Lonardi, Roberto Murialdo, Elena Ongaro, Francesca Pucci, Margherita Ratti, Nicola Silvestris, Valeria Smiroldo, Andrea Spallanzani, Antonia Strippoli, Stefano Tamberi, Emiliano Tamburini, Alberto Zaniboni, Maria Di Bartolomeo, Chiara Cremolini, Carlo Sposito, Vincenzo Mazzaferro, Filippo Pietrantonio
出版 2021Artigo
相關主題
Cancer
Internal medicine
Medicine
Oncology
Surgery
Adverse effect
Allele
Biochemistry
Chemistry
Chemotherapy
Clinical endpoint
Clinical trial
Cohort
Colorectal cancer
Docetaxel
Durvalumab
Environmental health
Febrile neutropenia
Gene
Immunotherapy
Ipilimumab
Microsatellite
Microsatellite instability
Neutropenia
Oxaliplatin
Pembrolizumab
Perioperative
Population
Surgical oncology
Tremelimumab